Veralto Signs Agreement To Acquire Cleanwater1
Veralto (VLTO) agreed to acquire Cleanwater1 for $465M, with a net price of $452M after tax benefits. The deal, expected to close in Q4 2026, adds ~25,000 units to Veralto's portfolio, expanding its water treatment offerings. Cleanwater1 had $135M in LTM sales, growing at a low double-digit CAGR since 2023. Veralto expects the acquisition to be neutral to modestly accretive to EPS in 2027.
How this was made
The 30-second read
Why it matters
The acquisition adds ~25,000 installed units and aims to generate recurring revenue, with modest EPS accretion expected in 2027.
Market read
A mid‑cap M&A deal that could lift Veralto's stock and influence the water‑treatment sector.
What to watch
Potential regulatory approvals and integration risk of Cleanwater1's technology could delay synergies.
Background
Veralto (NYSE: VLTO) is a global leader in water and product quality solutions. Cleanwater1 provides on‑site hypochlorite disinfection and solids management technologies.
Ticker impact
Veralto announced a definitive agreement to acquire Cleanwater1 for $465 million, a new M&A transaction.
Potential modest upside as the deal adds revenue and synergies; price may rise on announcement.
First‑report of a sizable $465 M deal with clear accretion guidance, likely to be priced in by the market.
Market effects
Expands Veralto's footprint in water treatment, potentially boosting the broader water infrastructure sector.
Strengthens the U.S. water technology market, with possible spillover to European and Asian suppliers.
Highlights continued consolidation in the global water treatment industry.
Counterpoint
Deal valuation at 17x EBITDA may be high if integration challenges arise, risking downside.
Key entities
- CompanyVeralto
Acquirer, listed on NYSE under VLTO.
- CompanyCleanwater1
Target, private water‑treatment firm.
